DHLAX
Price
$33.86
Change
+$0.16 (+0.47%)
Updated
Jul 25 closing price
Net Assets
8.43B
VIVAX
Price
$70.47
Change
+$0.29 (+0.41%)
Updated
Jul 25 closing price
Net Assets
195.18B
Interact to see
Advertisement

DHLAX vs VIVAX

Header iconDHLAX vs VIVAX Comparison
Open Charts DHLAX vs VIVAXBanner chart's image
Diamond Hill Large Cap I
Price$33.86
Change+$0.16 (+0.47%)
VolumeN/A
Net Assets8.43B
Vanguard Value Index I
Price$70.47
Change+$0.29 (+0.41%)
VolumeN/A
Net Assets195.18B
DHLAX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DHLAX vs. VIVAX commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DHLAX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 195B vs. DHLAX (8.43B). VIVAX pays higher dividends than DHLAX: VIVAX (2.06) vs DHLAX (1.04). DHLAX was incepted earlier than VIVAX: DHLAX (24 years) vs VIVAX (33 years). DHLAX (0.96) is less costly to investors than VIVAX (0.17). DHLAX is a more actively managed with annual turnover of: 36.00 vs. VIVAX (9.00). DHLAX has a lower initial minimum investment than VIVAX: DHLAX (2500) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 9.76 vs. DHLAX (-0.97). VIVAX return over 5 years is better than : 74.87 vs. DHLAX (33.96).
DHLAXVIVAXDHLAX / VIVAX
Total Expense Ratio0.960.17565%
Annual Report Gross Expense Ratio0.960.17565%
Fund Existence24 years33 years-
Gain YTD5.0576.72475%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets8.43B195B4%
Annual Yield % from dividends1.042.0650%
Returns for 1 year-0.979.76-10%
Returns for 3 years15.7634.3146%
Returns for 5 years33.9674.8745%
Returns for 10 years59.28116.3251%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PARWX57.320.30
+0.53%
Parnassus Value Equity Investor
GILLX23.900.10
+0.42%
Goldman Sachs Enhanced U.S. Equity Inst
VECRX22.330.07
+0.31%
Virtus KAR Equity Income R6
NZDCHF0.480.00
+0.21%
New Zealand Dollar - Switzerland Franc
FBTIX30.97N/A
N/A
Fidelity Advisor Biotechnology I